Logo image of 1RKLB.MI

ROCKET LAB CORP (1RKLB.MI) Stock Fundamental Analysis

BIT:1RKLB - US7731211089 - Common Stock

39.73 EUR
+2.68 (+7.25%)
Last: 9/8/2025, 7:00:00 PM
Fundamental Rating

3

Taking everything into account, 1RKLB scores 3 out of 10 in our fundamental rating. 1RKLB was compared to 41 industry peers in the Aerospace & Defense industry. The financial health of 1RKLB is average, but there are quite some concerns on its profitability. 1RKLB is valued quite expensive, but it does show an excellent growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

1RKLB had negative earnings in the past year.
In the past year 1RKLB has reported a negative cash flow from operations.
In the past 5 years 1RKLB always reported negative net income.
In the past 5 years 1RKLB always reported negative operating cash flow.
1RKLB.MI Yearly Net Income VS EBIT VS OCF VS FCF1RKLB.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -50M -100M -150M

1.2 Ratios

Looking at the Return On Assets, with a value of -14.89%, 1RKLB is doing worse than 90.24% of the companies in the same industry.
1RKLB's Return On Equity of -33.60% is on the low side compared to the rest of the industry. 1RKLB is outperformed by 85.37% of its industry peers.
Industry RankSector Rank
ROA -14.89%
ROE -33.6%
ROIC N/A
ROA(3y)-16.4%
ROA(5y)-18.08%
ROE(3y)-34.28%
ROE(5y)-34.08%
ROIC(3y)N/A
ROIC(5y)N/A
1RKLB.MI Yearly ROA, ROE, ROIC1RKLB.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 -10 -20 -30 -40 -50

1.3 Margins

The Gross Margin of 1RKLB (29.04%) is comparable to the rest of the industry.
1RKLB does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 29.04%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
1RKLB.MI Yearly Profit, Operating, Gross Margins1RKLB.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 -50 -100 -150

More info and screens

5

2. Health

2.1 Basic Checks

1RKLB does not have a ROIC to compare to the WACC, probably because it is not profitable.
1RKLB has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, 1RKLB has more shares outstanding
Compared to 1 year ago, 1RKLB has a worse debt to assets ratio.
1RKLB.MI Yearly Shares Outstanding1RKLB.MI Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M
1RKLB.MI Yearly Total Debt VS Total Assets1RKLB.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

An Altman-Z score of 15.11 indicates that 1RKLB is not in any danger for bankruptcy at the moment.
1RKLB has a Altman-Z score of 15.11. This is amongst the best in the industry. 1RKLB outperforms 100.00% of its industry peers.
1RKLB has a Debt/Equity ratio of 0.60. This is a neutral value indicating 1RKLB is somewhat dependend on debt financing.
1RKLB has a Debt to Equity ratio (0.60) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.6
Debt/FCF N/A
Altman-Z 15.11
ROIC/WACCN/A
WACC9.58%
1RKLB.MI Yearly LT Debt VS Equity VS FCF1RKLB.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

1RKLB has a Current Ratio of 2.67. This indicates that 1RKLB is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of 1RKLB (2.67) is better than 95.12% of its industry peers.
A Quick Ratio of 2.33 indicates that 1RKLB has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 2.33, 1RKLB belongs to the top of the industry, outperforming 95.12% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.67
Quick Ratio 2.33
1RKLB.MI Yearly Current Assets VS Current Liabilites1RKLB.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 200M 400M 600M

More info and screens

7

3. Growth

3.1 Past

1RKLB shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -28.57%.
1RKLB shows a strong growth in Revenue. In the last year, the Revenue has grown by 54.37%.
The Revenue has been growing by 55.23% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-28.57%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-62.5%
Revenue 1Y (TTM)54.37%
Revenue growth 3Y91.41%
Revenue growth 5Y55.23%
Sales Q2Q%36%

3.2 Future

1RKLB is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 32.40% yearly.
Based on estimates for the next years, 1RKLB will show a very strong growth in Revenue. The Revenue will grow by 32.13% on average per year.
EPS Next Y-16.61%
EPS Next 2Y27.89%
EPS Next 3Y31.1%
EPS Next 5Y32.4%
Revenue Next Year34.29%
Revenue Next 2Y43.15%
Revenue Next 3Y40.51%
Revenue Next 5Y32.13%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
1RKLB.MI Yearly Revenue VS Estimates1RKLB.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 1B 2B 3B
1RKLB.MI Yearly EPS VS Estimates1RKLB.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 0 0.2 -0.2 -0.4

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

1RKLB reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for 1RKLB. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
1RKLB.MI Price Earnings VS Forward Price Earnings1RKLB.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -100 -200 -300

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
1RKLB.MI Per share data1RKLB.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1

4.3 Compensation for Growth

A more expensive valuation may be justified as 1RKLB's earnings are expected to grow with 31.10% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y27.89%
EPS Next 3Y31.1%

More info and screens

0

5. Dividend

5.1 Amount

1RKLB does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ROCKET LAB CORP

BIT:1RKLB (9/8/2025, 7:00:00 PM)

39.73

+2.68 (+7.25%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)08-07 2025-08-07/amc
Earnings (Next)11-10 2025-11-10/amc
Inst Owners61.47%
Inst Owner ChangeN/A
Ins Owners0.68%
Ins Owner ChangeN/A
Market Cap19.17B
Analysts79.05
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-1.65%
Min EPS beat(2)-11.38%
Max EPS beat(2)8.09%
EPS beat(4)3
Avg EPS beat(4)3.2%
Min EPS beat(4)-11.38%
Max EPS beat(4)12.21%
EPS beat(8)7
Avg EPS beat(8)8.2%
EPS beat(12)8
Avg EPS beat(12)4.25%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)1.82%
Min Revenue beat(2)-0.99%
Max Revenue beat(2)4.63%
Revenue beat(4)2
Avg Revenue beat(4)0.87%
Min Revenue beat(4)-0.99%
Max Revenue beat(4)4.63%
Revenue beat(8)2
Avg Revenue beat(8)-1.29%
Revenue beat(12)5
Avg Revenue beat(12)-0.34%
Revenue beat(16)8
Avg Revenue beat(16)1.42%
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)-5.65%
EPS NQ rev (3m)-83.77%
EPS NY rev (1m)-5.35%
EPS NY rev (3m)-6.55%
Revenue NQ rev (1m)0.65%
Revenue NQ rev (3m)-2.9%
Revenue NY rev (1m)1.19%
Revenue NY rev (3m)0.87%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 44.64
P/FCF N/A
P/OCF N/A
P/B 32.69
P/tB 39.94
EV/EBITDA N/A
EPS(TTM)-0.38
EYN/A
EPS(NY)-0.11
Fwd EYN/A
FCF(TTM)-0.36
FCFYN/A
OCF(TTM)-0.2
OCFYN/A
SpS0.89
BVpS1.22
TBVpS0.99
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -14.89%
ROE -33.6%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 29.04%
FCFM N/A
ROA(3y)-16.4%
ROA(5y)-18.08%
ROE(3y)-34.28%
ROE(5y)-34.08%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.32
Health
Industry RankSector Rank
Debt/Equity 0.6
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 268.86%
Cap/Sales 18.5%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.67
Quick Ratio 2.33
Altman-Z 15.11
F-Score4
WACC9.58%
ROIC/WACCN/A
Cap/Depr(3y)174.96%
Cap/Depr(5y)206.2%
Cap/Sales(3y)19.28%
Cap/Sales(5y)34.12%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-28.57%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-62.5%
EPS Next Y-16.61%
EPS Next 2Y27.89%
EPS Next 3Y31.1%
EPS Next 5Y32.4%
Revenue 1Y (TTM)54.37%
Revenue growth 3Y91.41%
Revenue growth 5Y55.23%
Sales Q2Q%36%
Revenue Next Year34.29%
Revenue Next 2Y43.15%
Revenue Next 3Y40.51%
Revenue Next 5Y32.13%
EBIT growth 1Y-28.41%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year55.45%
EBIT Next 3Y44.65%
EBIT Next 5Y31.86%
FCF growth 1Y-70.08%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-50.93%
OCF growth 3YN/A
OCF growth 5YN/A